Fengyuan Pharmaceutical's (000153.SZ) subsidiary obtains approval for tirofiban hydrochloride API for market launch.

Zhitong Finance APP News, Fengyuan Pharmaceutical (000153.SZ) announced that recently, its wholly-owned subsidiary Bengbu Fengyuan Tushan Pharmaceutical Co., Ltd. received the "Chemical Active Pharmaceutical Ingredient Marketing Application Approval Notification" for Tirofiban Hydrochloride approved and issued by the National Medical Products Administration.